EGeen is a global CRO, headquartered in Mountain View, California, with sales offices in Maryland, and London, UK. Our business is to advance the drug development of biotech and pharmaceutical companies by offering fast, high quality and cost-effective clinical trial management services.
EGeen representatives will attend the 125th DCAT week in New York City on March 16 - March 19, 2015
Impax's Rytary for Parkinson's disease gets FDA approval.
EGeen representatives attend the J.P. Morgan 33rd Annual Healtcare Conference in San Francisco on January 12, 2015 - January 15, 2015.